RIT biomedical engineering researchers identify a protein that can reduce fibrosis and slow disease progression.

A collaborative effort led by Professor Wanli Liu 's team at Tsinghua University has uncovered a sophisticated mechanism by ...

A new study shows that people with high blood pressure can lower their risk of heart disease and type 2 diabetes, and may ...

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that a moderated ...

Funding from MJFF and Wellcome supports expansion into Parkinson’s and PTSD Lario Therapeutics has secured $2.4 million in new grant funding from The Michael J Fox Foundation for Parkinson’s Research ...

Aisa Pharma has reported positive results from its Phase II RECONNOITER trial of AISA-021 (cilnidipine), a once-daily calcium ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

A new genomic study isolates a mania-specific factor that explains over 80% of bipolar disorder’s genetic risk, tying it to ...

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative ...

SISSA Colloquium returns on Wednesday, March 18th, at 2 PM in Aula Magna Budinich. This time, we will have the pleasure of hosting Professor Huib Mansvelder (Vrije Universiteit Amsterdam), who will ...

Severe hypothyroidism is associated with a high burden of systolic/diastolic ventricular dysfunction and myocardial ...

Those dealing with severe cases of Raynaud's Syndrome can talk to their doctor about Calcium channel blockers to relax blood ...